Care and Empathy From a Nurse Inspire Former Pediatrics Patient to Become a Physician

When Naysha Lopez, MD, received her medical degree, Evelyn Sotomayor, RN, the Mount Sinai nurse who helped care for her in 2004, was there to celebrate.

When Naysha Lopez graduated from the University of Puerto Rico School of Medicine in June, Evelyn Sotomayor, RN, a pediatric nurse in the intensive care unit (ICU) at Kravis Children’s Hospital at Mount Sinai, was in the audience. It was no surprise that Ms. Sotomayor would travel more than 1,500 miles to be by Naysha’s side—this was another celebratory milestone in a long journey that first brought them together in 2004.

In August of that year, 13-year-old Naysha woke up one morning not feeling well, and by the time she got home from school, her skin and eye tone were yellow, and she had considerable abdominal pain.

Her doctor in Carolina, outside San Juan, Puerto Rico, diagnosed liver failure, and he immediately arranged for a medical plane to take her to The Mount Sinai Hospital, widely renowned as a center for adult and pediatric liver transplants.

Thirteen-year-old Naysha Lopez with Evelyn Sotomayor, RN, at Kravis Children’s Hospital at Mount Sinai.

At Mount Sinai, doctors determined she had Wilson disease, an inherited condition that prevents the liver from filtering excess copper from the body correctly, causing organ damage. They initially feared she had 12 hours to live, and they placed Naysha at the top of the transplant list. A match was found one week later, and, on August 27, Mount Sinai surgeons transplanted the donated liver during a 10-hour surgery.

The family recalls a scary and lonely time. In addition to the stress of a life-threatening illness, they didn’t speak English, were strangers to New York, and had limited financial resources. But good fortune intervened: Ms. Sotomayor, a New Yorker of Puerto Rican descent, immediately took Naysha and her parents under her wing in the ICU, explaining what to expect throughout the illness, reassuring them, and giving them hope. She also showed Naysha’s parents how to use the subway and where to shop for food and clothing.

When Naysha was transferred out of the ICU to another unit, Ms. Sotomayor visited Naysha’s bedside at the end of her shift, braiding her hair while encouraging her to be brave. “Sometimes when you’re sick, all you want is someone to talk to,” Naysha recalls. “Evelyn went above and beyond to show us she cared.” They talked for hours, and envisioned a future beyond the illness. Ms. Sotomayor even suggested that Naysha become a doctor, noting that her experience would give her a unique perspective.

After two months of hospitalization, when Naysha was transferred to the Transplant Living Center to continue her recovery, it was Ms. Sotomayor who brought her there, on her day off, to help her get settled. When Naysha was stronger, Ms. Sotomayor took the family on a Circle Line cruise and brought them to her Long Island home for the weekend.

Naysha Lopez at her high school prom with Evelyn Sotomayor, RN, in 2009.

In December 2004, fully recovered, Naysha and her family returned to Puerto Rico, where they have kept in touch with Ms. Sotomayor, who over the years has attended many of Naysha’s milestones, including her quinceañera—the traditional birthday celebration for Latina girls when they turn 15—and her high school prom and graduation. “She is like family,” says Naysha, who also recalls the excellent care she received from her entire medical team, and social workers who raised donations for the family and brought in a teacher to help with her schoolwork.

In July, as Naysha—now Dr. Lopez—begins her residency in Emergency Medicine in Carolina, she continues to be inspired by her own experience at Mount Sinai, and, most significantly, by Ms. Sotomayor. “She showed me how rewarding it is to take care of people. Because of Evelyn, I trust nurses and have tremendous respect for the role they play in healing their patients.”

Adds Ms. Sotomayor, “I feel blessed that they have been in my life. I feel good when I can help people and give them hope. That’s the best feeling of all.”

Third Episode of Mount Sinai Future You

The third episode of Mount Sinai Future You features a 22-year-old man from Idaho with a rare facial tumor called a lymphangioma. Following two dozen unsuccessful surgeries, he sought treatment from Gregory Levitin, MD, Director of Vascular Birthmarks and Malformations at New York Eye and Ear Infirmary of Mount Sinai, and one of the only surgeons in the country with expertise resecting these types of tumors.

Mount Sinai Future You, which highlights innovation at Mount Sinai, is being broadcast on CUNY TV, the non-commercial educational-access cable channel run by The City University of New York.

Mount Sinai Future You takes viewers behind the scenes as doctors at Mount Sinai Health System leverage innovative science to change patients’ lives every day. The series  highlights preventative care and treatment models that will lead to better health and longer lives.

Mount Sinai Future You, Episode Three, also features:

  • An interview with Paula Klein, MD, Medical Director of Breast Cancer Clinical Trials and Charles Shapiro, MD, Director of Translational Breast Cancer Research, on new technologies allowing breast cancer patients undergoing chemotherapy to keep their hair during treatment and the latest research allowing many early-stage breast cancer patients to avoid using chemotherapy.
  • David Stark, MD, Director of Lab 100, discusses the hybrid clinic-research lab that is leveraging data from physical fitness and cognitive tests to help doctors obtain a more comprehensive health assessment of their patients.
  • Sam Gandy, MD, PhD, Associate Director of Mount Sinai Alzheimer’s Disease Research Center, and Joel Dudley, PhD, Director of the Institute for Next Generation Healthcare, discover a link between strains of the herpes virus and Alzheimer’s disease.
  • Kevin Costa, PhD, Director of Cardiovascular Cell and Tissue Engineering, shares the latest research on stem cells that are engineered to create new heart cells.

New episodes of Mount Sinai Future You will run monthly, in the first week of each month, on Wednesdays at 9:30 pm, Thursdays at 6:30 am and 5 pm, and Saturdays at 11 am. They will cover newsworthy topics in medicine, as well as highlight new treatments, innovations, and preventive care for patients. The series is produced by Mount Sinai.

Here is where you can find this series:

Cable System CUNY TV Channel
Spectrum 75
Cablevision 75
Optimum Brooklyn 75
RCN Cable 77
Verizon FiOS 30

 *Some RCN digital cable and MMDS systems carry CUNY TV and/or NYC TV on different channel numbers. For example, some RCN systems in Manhattan and Queens carry CUNY TV on channel 24, 106 or 108. Please consult your cable provider directly to be sure.

Conference Addresses Lack of Research on Female Brain Injury

Speaker Trisha Meili discussed coming to terms with brain injury.

The Friedman Brain Institute (FBI) in May cosponsored a program with the Brain Injury Research Center of Mount Sinai and the Department of Rehabilitation Medicine that focused attention on the little-known and -discussed incidence of traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE) in women. CTE is a neurotrauma-associated neurodegenerative condition that is most often found in males who are professional athletes and soldiers.

The program, held in Goldwurm Auditorium and hosted in conjunction with the nonprofit organization Pink Concussions, addressed the lack of research on CTE in women and highlighted its prevalence among females who sustain head trauma each year as a result of sports injuries, accidents, domestic violence, or military duty.

In his opening remarks, Eric Nestler, MD, PhD, Nash Family Professor of Neuroscience, Director of The Friedman Brain Institute, and Dean for Academic and Scientific Affairs, Icahn School of Medicine at Mount Sinai, said, “We know that lack of knowledge and an inability to treat brain injury in women and girls is a major gap in the medical profession.”

Pink Concussions founder Katherine Price Snedaker, LCSW, said she began researching the subject of brain injury when one of her sons sustained five concussions from playing sports. After hearing from the mothers of daughters who were also repeatedly experiencing them, she created a support group, which ultimately led to the establishment of Pink Concussions in 2013.

Dara Dickstein, PhD, an Adjunct Assistant Professor in the Department of Neuroscience at the Icahn School of Medicine and a co-organizer of the event, presented research she is conducting that involves neuroimaging and the use of biomarkers to aid in the diagnosis of CTE during life. Currently, the only way CTE can be definitely diagnosed is through postmortem brain analysis at autopsy. Dr. Dickstein is studying the potential efficacy of an experimental radioactive tracer that binds to tau (proteins that build up in the brains of CTE sufferers) and shows up on PET scans, to help diagnose the condition during life.

At the Mount Sinai event, Yelena Goldin, PhD, Staff Neuropsychologist at Hackensack Meridian Health in Edison, N.J., explained that after reviewing thousands of studies on outcomes of traumatic brain injury, her team could find only 54 that factored sex and gender into their analyses. Additionally, Dr. Goldin said, there was no follow-up medical literature on female athletes in high school and college six months after they had recovered and were medically cleared to return to their sports.

One of the program’s speakers, a woman who experienced injuries to her head as a result of domestic violence, said the lack of medical or scientific research left her confused about her subsequent health problems, including menstrual issues, forgetfulness, depression, and anxiety. “At the time,” she said, “the only advice I got was that I would probably get some migraines.”

Kristen Dams-O’Connor, PhD, Director of the Brain Injury Research Center at the Mount Sinai Health System and a co-organizer of the event, said recent studies from her group have not revealed any connection between traumatic brain injury and Alzheimer’s disease, although they did find damage to small blood vessels and the presence of Lewy bodies—abnormal deposits of protein, which are implicated in Parkinson’s disease.

Plenary speaker Trisha Meili said the lack of a definitive link between TBI and Alzheimer’s was welcome news to her. In April 1989, Ms. Meili, a young investment banker, survived a brutal attack while jogging in Central Park. The attack—which included a life-threatening blow to her head—made headlines around the world.

During the program, Ms. Meili discussed her recovery and her life today. “Mentally, I will never be the same as I was before the brain injury,” she said. “Acknowledging this to myself, needless to say, is not a great feeling. But in another way, it gives me peace. I can live with it. I accept it. It’s a giant step in my healing.”

At Reunion, Alumni Celebrate 50th Anniversary of Icahn School of Medicine at Mount Sinai

Alumni toured the Innovators in Science and Medicine display at Guggenheim Pavilion.

More than 200 alumni gathered recently to celebrate 50 years of education at the Icahn School of Medicine at Mount Sinai’s annual Alumni Reunion and Awards Ceremony.

Eleven distinguished alumni of the Icahn School of Medicine and St. Luke’s-Roosevelt (SLR) received awards at the event on Wednesday, May 16, at the New York Academy of Medicine. The event also included a keynote discussion by two panelists on the diverse communities cared for by the Mount Sinai Health System: Theresa A. Soriano, MD, MPH, ISMMS 2001, Professor of Medicine, and Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, spoke about patients’ social and economic challenges, and Scott Jelinek, MD, ISMMS 2018, focused on Mount Sinai’s leadership in caring for lesbian, gay, bisexual, and transgender patients.

Both physicians represent the future of medical care, said David Muller, MD, Dean for Medical Education, and the Marietta and Charles C. Morchand Chair for Medical Education, Icahn School of Medicine at Mount Sinai. “People like Scott and Theresa make us better. They make us a better school, better people, better doctors,” Dr. Muller said.

Before the ceremony, current medical students presented research projects to alumni and led a tour of the School of Medicine. The anatomy lab and the library were familiar to all, but alumni were intrigued by some newer aspects of student life. For example, students who do not attend lectures in person can watch later on videos—sometimes playing them at double speed to save time. And most exams can be taken online. “The tests are timed, but you can take them in your bedroom, or wherever you have Wi-Fi,” said tour guide Evan Garden, Class of 2021. “There are so many initiatives to improve student wellness, and this is definitely one of the more popular ones.”

The tour ended at Guggenheim Pavilion, site of a major exhibition of Innovators in Science and Medicine. The display focuses on the work of 48 physicians and scientists at the Icahn School of Medicine at Mount Sinai who have made advances in fields as diverse as genomics, immunology, orthopedics, transplant surgery, environmental health, and equity in health care. The innovators all have a common goal, the exhibition states: “Striving to generate better scientific understanding and treatments that will change lives.”

The alumni award winners were:

The Saul Horowitz, Jr. Memorial Award: Mitchell B. Cohen, MD, MSSM ’77

The J. Lester Gabrilove Award: Bonnie M. Davis, MD, MSSM, ’73

The Mount Sinai Alumni Special Recognition Award: Richard R.P. Warner, MD, MSH ’61

The Mount Sinai Alumni Award for Achievement in Medical Education: Claude Bloch, MD, FACR, MSH ’60

The Mount Sinai Alumni Award for Achievement in Medical Education: Rainier P. Soriano, MD, MSH ’99

The Dr. Sidney Grossman Distinguished Humanitarian Award: Ann Marie Beddoe, MD, MPH

The Mount Sinai Alumni Student Leadership Award: Benjamin M. Laitman, PhD, MD, ISMMS ’18

The Terry Ann Krulwich Physician-Scientist Alumni Award: Ayotunde Dokun, MD, PhD, MSSM ’03

The Mount Sinai Alumni Award for Achievement in Graduate Education: Ana Fernandez-Sesma, PhD, MSSM ’98

St. Luke’s-Roosevelt Distinguished Alumnus Award: George Todd, MD

St. Luke’s-Roosevelt Distinguished Young Physician of the Year: Shanna K. Patterson, MD

 

 

Fast-Tracking Research Discoveries to Help Patients

Erik Lium, PhD, center, with Yiannis Ioannou, PhD, left, and Sean Ianchulev, MD, MPH.

More than 100 researchers, venture capital firms, and entrepreneurs attended the launch event at Davis Auditorium on Thursday, April 12, for the Mount Sinai Innovation Partners accelerator fund that will provide commercial and business-development support to advance research discoveries that have great potential to help patients on a global scale.

The i3 Asset Accelerator (“innovation,” “inflection,” and “impact”) was established with an initial investment of $10 million over four years and additional philanthropic support, and is already funding two initial projects that aim to develop promising drug candidates for cancer and therapies for influenza B viral infections.

“Mount Sinai is making a major commitment to this initiative to ensure that we are bringing Mount Sinai discoveries to life,” Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, told the audience.

“The i3 Asset Accelerator is very important to us. It’s what we’re all about, translating great science and helping our patients.” With an advisory team of more than 40 scientists, business professionals, and commercialization experts, i3 provides funding and mentorship to advance nascent Mount Sinai technologies that will create partnerships and rapidly develop data that will reach the patient population. “i3 is the next step in engaging with the members of our life sciences innovation community, building upon our translational competencies, and evolving our commercial ecosystem to create major breakthroughs in health care,” said Erik Lium, PhD, Executive Vice President, Mount Sinai Innovation Partners.

The event also included a discussion on health care technology and the importance of i3, which was moderated by Dr. Lium and included Icahn School of Medicine at Mount Sinai panelists Sean Ianchulev, MD, MPH, Professor of Ophthalmology, and Director of the Ophthalmic Innovation and Technology Program at the New York Eye and Ear Infirmary of Mount Sinai; and Yiannis Ioannou, PhD, Professor of Genetics and Genomic Sciences.

Health System Receives Leadership Award

Gary C. Butts, MD, left, and Dennis S. Charney, MD, at the Champions of Health Awards event, where the Mount Sinai Health System was honored.

The Mount Sinai Health System has received the National Medical Fellowships (NMF) Leadership in Diversity Award. Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, accepted the award on Wednesday, May 9, at NMF’s Champions of Health Awards event in Manhattan.

“It is important that we continue to support NMF and continue to build on its mission to change the face of medicine,” Dr. Charney said. NMF is a nonprofit organization dedicated to providing scholarships and support to students in minority groups underrepresented in health care. Gary C. Butts, MD, Mount Sinai Health System, has a distinguished history with the group. He received a fellowship as a young medical student and accepted a lifetime achievement award in 2016.